In bronchopulmonary tissue, PM2.5 can stimulate kallikrein expression and the release of bradykinin (BK), and kallikrein inhibitors can reverse these alterations, demonstrating that kallikrein is relevant in PM2.5-induced airway hyperresponsiveness (17). The gene discussed is KNG1; the disease is airway hyperresponsiveness.